LAG3 and neoplasm: Furthermore, the hypomethylation of LAG3 promoter and the hypermethylation of the CTCF binding cite may increase the infiltration of immune cells (35), indicating that the methylation of LAG3 may become a new epigenetic marker for tumor immune cell infiltration.